BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1979729)

  • 1. [Renal effects of intravenous tertatolol in essential arterial hypertension].
    Chaignon M; Brouard R; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension.
    Chaignon M; Barrou Z; Ayad M; Lucsko M; Aubert P; Perret L; Guedon J
    J Hypertens Suppl; 1988 Dec; 6(3):S61-4. PubMed ID: 3225690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of tertatolol and nadolol on systemic and renal hemodynamics in patients with essential hypertension.
    Degaute JP; Naeije R; Abramowicz M; Leeman M; Schoutens A; Prost JF
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):263S-268S. PubMed ID: 3415803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereospecificity of beta-adrenoceptor blockade and renal vasodilatation by tertatolol.
    Smits JF; Zeegers HH; Struyker-Boudier HA
    Arch Int Pharmacodyn Ther; 1989; 298():164-71. PubMed ID: 2569294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F; Lantz B; Leviel F; Ardaillou R
    Am J Nephrol; 1986; 6 Suppl 2():40-4. PubMed ID: 2879472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tertatolol--characteristics of the drug].
    Tomaszewski R; Kliz J
    Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta blockers induce different intrarenal effects in humans: demonstration by selective infusion of tertatolol and propranolol.
    Nitenberg A; Chemla D; Blanchet F; Guery O; Prost JF; Dutray-Dupagne C
    J Clin Pharmacol; 1990 Oct; 30(10):930-7. PubMed ID: 1977772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tertatolol ameliorates renal function in rats with chronic renal failure.
    Delaini F; Perico N; Tagliaferri M; Lupini C; Patino O; Remuzzi G; Garattini S
    J Pharmacol Exp Ther; 1988 Jul; 246(1):287-93. PubMed ID: 2899165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tertatolol on renal function in the isolated perfused rat kidney.
    Perico N; Remuzzi G
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):223S-227S. PubMed ID: 2573368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
    Plante GE; Prévost C; Sirois P; Rochat C; Prost JF
    J Pharmacol Exp Ther; 1989 Feb; 248(2):741-6. PubMed ID: 2563770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of novel renal properties of tertatolol.
    Guillet C
    Cardiology; 1993; 83 Suppl 1():64-9. PubMed ID: 7903218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional hemodynamic effects of the beta-adrenoceptor blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
    Nievelstein HM; Tijssen CM; Smits JF; Struyker-Boudier HA
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):118-29. PubMed ID: 2876684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tertatolol in hypertensive patients with chronic renal failure.
    Beaufils M; Lantz B; Paillard F; Richet G
    Am J Nephrol; 1986; 6 Suppl 2():50-4. PubMed ID: 2879474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamic effects of tertatolol compared with those of propranolol in the conscious dog.
    Laubie M; Prost JF; Rochat C
    Am J Nephrol; 1986; 6 Suppl 2():20-4. PubMed ID: 2879468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
    Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved renal perfusion during beta blockade by tertatolol with and without cyclooxygenase inhibition in normal humans.
    Reuse C; Leeman M; Degaute JP; Abramowicz M; Prost JF; Naeije R
    J Clin Pharmacol; 1988 Apr; 28(4):312-6. PubMed ID: 3134468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of inhibition of converting enzyme by perindopril on renal hemodynamics and natriuresis in essential arterial hypertension].
    Chaignon M; Barrou Z; Ayad M; Guédon J
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():151-4. PubMed ID: 3142399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.